Fenomenul de bounce PSA dupČ brahiterapia prin implant permanent cu I în cancerul de prostată localizat - factori de predicţie clinici şi dozimetrici. Source: Romanian Journal of Urology.
Cuvinte cheie hiperplazie benignă de prostată IRM multiparametrică cancer de prostată PI-RADS imagistică medicală Introduction Benign prostatic hyperplasia BPH is a histologic diagnosis characterized by proliferation of the prostatic cellular elements.
Dec, Vol. Author s : Hăineală, B. Guler; Sinescu, I. Abstract: Introduction and Objectives: The purpose of the study is to evaluate the incidence, time of occurrence and magnitude of PSA bounce phenomenon BP after permanent prostate implant with I, clinical and dosimetric factors favoring the occurrence of this phenomenon and its impact on biochemical relapse.
Material and Methods: Between October - July were treated with permanent prostate implant with I a total of patients with prostate cancer, alone in stage T1c-T2a.
PSA bounce is defined as a temporary increase in PSA value followed by a consecutive decrease recorded with the same value before the increase or a lower value. PSA bounce phenomenon was recorded in 31 patients Results: The average magnitude's bounce was 1.
Mean PSA at 12 months for patients on monotherapy who did not show bounce phenomenon was 0. For patients who showed no BP average D90 was Initial PSA values, Gleason score, preoperative prostate volume did not affect this process.
The data underlying this article will be shared on reasonable request to the corresponding author. So far, studies evaluating semen quality and the occurrence of SARS-CoV-2 in semen of infected or proven recovered men are scarce and included a limited number of participants. Four biological fluid samples, namely saliva, pre-ejaculation urine, semen, and post-ejaculation urine, were tested for the SARS-CoV-2 genome.
Conclusions: PSA bounce is not a rare phenomenon after prostate brachytherapy and should be always considered whenever we have a patient with rising PSA after implant, especially when the perioud of time that has passed since the procedure is not long. It occurs more frequently in younger patients and is not related to preoperative clinical and dosimetry factors.
Copyright of Romanian Journal of Urology is the property of Romanian Journal of Urology and its content prostate gland normal size ml not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission.
However, users may print, download, or email articles for individual use.
This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.
Prostate Health Month: Does Size of the Prostate Matter?
Important User Information: Remote access to EBSCO's databases is permitted to patrons of subscribing institutions accessing from remote locations for personal, non-commercial use.
However, remote access to EBSCO's databases from non-subscribing institutions is not allowed if the purpose of the use is for commercial gain through cost reduction or avoidance for new prostate cancer test 2022 non-subscribing institution.
Prostatitis and benign prostatic hyperplasia BPH are two common conditions that affect the prostate. Although both can lead to pain and difficulty. Each person reacts in his own way to the symptoms of benign prostatic hyperplasia BPHa common condition for men as they age. Un individ care are doua rude de gradul I cu cancer de prostata, are o crestere de 9 ori mai mare in Gena HPC1 cancerul de prostată ereditar 1 și gena PCAP predispozant pentru cancerul.